Trial intelligence / Profile preview

Oxycodone premedication versus no premedication for pain control after total hip endoprosthesis

2005-001791-13Phase 3Terminated

Sponsor
Mundipharma
Start
Jun 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of oxycodone and diclofenac in postoperative pain (2 arms), sponsored by Mundipharma. Primary endpoints: Primary efficacy variable and Analgesic need. Started Jun 2005; status: terminated.

02

Drugs

oxycodonediclofenac
03

Conditions

postoperative pain

Beyond the preview

Go deeper on 2005-001791-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-001791-13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call